Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Ebiomedicine|August 19, 2022
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
Blood|September 22, 2023
TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysisPietro Merli, Mattia Algeri, Federica Galaverna, et al.
Science Advances|January 21, 2022
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemiaCuijuan Han, Alireza Khodadadi-Jamayran, Adam H Lorch, et al.
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.
Hemasphere|September 4, 2025
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapyGunnar Cario, Maria Grazia Valsecchi, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyValentino Conter, Maria Grazia Valsecchi, Gunnar Cario, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALLKristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Leukemia|June 26, 2026
Plasticity under pressure: biology and detection of lineage switch in acute leukemiaAlexandra E Kovach, Yang-Yang Ding, Adam J Lamble, et al.
Blood|January 12, 2024
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatmentBarbara Buldini, Elena Varotto, Margarita Maurer-Granofszky, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Pageof 9